Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Ultrastructural Lesions of Nodo-Paranodopathies in Peripheral Neuropathies.

Vallat JM, Magy L, Corcia P, Boulesteix JM, Uncini A, Mathis S.

J Neuropathol Exp Neurol. 2020 Mar 1;79(3):247-255. doi: 10.1093/jnen/nlz134.

PMID:
31923310
2.

Comparison of clinical and electrophysiological features of patients with hereditary neuropathy with liability to pressure palsies with or without pain.

Lefour S, Gallouedec G, Magy L.

J Neurol Sci. 2020 Feb 15;409:116629. doi: 10.1016/j.jns.2019.116629. Epub 2019 Dec 16.

PMID:
31862515
3.

Antibody- and macrophage-mediated segmental demyelination in chronic inflammatory demyelinating polyneuropathy: clinical, electrophysiological, immunological and pathological correlates.

Vallat JM, Mathis S, Vegezzi E, Richard L, Duchesne M, Gallouedec G, Corcia P, Magy L, Uncini A, Devaux J.

Eur J Neurol. 2020 Apr;27(4):692-701. doi: 10.1111/ene.14133. Epub 2019 Dec 22.

PMID:
31769579
4.

Implication of the SH3TC2 gene in Charcot-Marie-Tooth disease associated with deafness and/or scoliosis: Illustration with four new pathogenic variants.

Lerat J, Magdelaine C, Lunati A, Dzugan H, Dejoie C, Rego M, Beze Beyrie P, Bieth E, Calvas P, Cintas P, Delaubrier A, Demurger F, Gilbert-Dussardier B, Goizet C, Journel H, Laffargue F, Magy L, Taithe F, Toutain A, Urtizberea JA, Sturtz F, Lia AS.

J Neurol Sci. 2019 Nov 15;406:116376. doi: 10.1016/j.jns.2019.06.027. Epub 2019 Jun 26.

PMID:
31634715
5.

Hearing loss in inherited peripheral neuropathies: Molecular diagnosis by NGS in a French series.

Lerat J, Magdelaine C, Roux AF, Darnaud L, Beauvais-Dzugan H, Naud S, Richard L, Derouault P, Ghorab K, Magy L, Vallat JM, Cintas P, Bieth E, Arne-Bes MC, Goizet C, Espil-Taris C, Journel H, Toutain A, Urtizberea JA, Boespflug-Tanguy O, Laffargue F, Corcia P, Pasquier L, Fradin M, Napuri S, Ciron J, Boulesteix JM, Sturtz F, Lia AS.

Mol Genet Genomic Med. 2019 Sep;7(9):e839. doi: 10.1002/mgg3.839. Epub 2019 Aug 8.

6.

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.

Laplaud DA, Casey R, Barbin L, Debouverie M, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Lubetzki C, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Wahab A, Labauge P, Magy L, Defer G, Guennoc AM, Maubeuge N, Labeyrie C, Patry I, Nifle C, Casez O, Michel L, Rollot F, Leray E, Vukusic S, Foucher Y; SFSEP and OFSEP groups.

Neurology. 2019 Aug 13;93(7):e635-e646. doi: 10.1212/WNL.0000000000007938. Epub 2019 Jul 12.

7.

[Pharmacological management of neuropathic pain].

Bouchenaki H, Bégou M, Magy L, Hajj R, Demiot C.

Therapie. 2019 Dec;74(6):633-643. doi: 10.1016/j.therap.2019.04.003. Epub 2019 Apr 13. French.

PMID:
31097329
8.

Focus on 1,25-Dihydroxyvitamin D3 in the Peripheral Nervous System.

Faye PA, Poumeaud F, Miressi F, Lia AS, Demiot C, Magy L, Favreau F, Sturtz FG.

Front Neurosci. 2019 Apr 12;13:348. doi: 10.3389/fnins.2019.00348. eCollection 2019. Review.

9.

Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions.

Ayrignac X, Rigau V, Lhermitte B, Vincent T, de Champfleur NM, Carra-Dalliere C, Charif M, Collongues N, de Seze J, Hebbadj S, Ahle G, Oesterlé H, Cotton F, Durand-Dubief F, Marignier R, Vukusic S, Taithe F, Cohen M, Guennoc AM, Kerbrat A, Edan G, Carsin-Nicol B, Allou T, Sablot D, Thouvenot E, Ruet A, Magy L, Boncoeur-Martel MP, Labauge P, Kremer S.

J Neurol. 2019 Jul;266(7):1743-1755. doi: 10.1007/s00415-019-09328-7. Epub 2019 Apr 23.

PMID:
31016376
10.

LRSAM1 variants and founder effect in French families with ataxic form of Charcot-Marie-Tooth type 2.

Peretti A, Perie M, Vincent D, Bouhour F, Dieterich K, Mallaret M, Duval F, Goizet C, Juntas-Morales R, Magy L, Solé G, Nollet S, Not A, Léonard-Louis S, Francou B, Leguern E, Lia AS, Magdelaine C, Latour P, Stojkovic T.

Eur J Hum Genet. 2019 Sep;27(9):1406-1418. doi: 10.1038/s41431-019-0403-8. Epub 2019 Apr 17.

PMID:
30996334
11.

Does intravenous immunoglobulin therapy in Guillain-Barré syndrome patients interfere with serological Zika detection?

Karnam A, Stephen-Victor E, Das M, Magy L, Vallat JM, Bolgert F, Simon-Loriere E, Kaveri SV, Sakuntabhai A, Bayry J.

Autoimmun Rev. 2019 Jun;18(6):632-633. doi: 10.1016/j.autrev.2019.01.004. Epub 2019 Apr 5. No abstract available.

PMID:
30959213
12.

Rodent models with expression of PMP22: Relevance to dysmyelinating CMT and HNPP.

Jouaud M, Mathis S, Richard L, Lia AS, Magy L, Vallat JM.

J Neurol Sci. 2019 Mar 15;398:79-90. doi: 10.1016/j.jns.2019.01.030. Epub 2019 Jan 21. Review.

PMID:
30685714
13.

Some new proposals for the classification of inherited myopathies.

Mathis S, Tazir M, Solé G, Magy L, Le Masson G, Couratier P, Ghorab K, Duval F, Lacoste I, Goizet C, Vallat JM.

J Neurol Sci. 2018 Aug 15;391:118-119. doi: 10.1016/j.jns.2018.06.014. Epub 2018 Jun 19. No abstract available.

PMID:
30103959
14.

Neuroprotective effect of angiotensin II type 2 receptor stimulation in vincristine-induced mechanical allodynia.

Bessaguet F, Danigo A, Bouchenaki H, Duchesne M, Magy L, Richard L, Sturtz F, Desmoulière A, Demiot C.

Pain. 2018 Dec;159(12):2538-2546. doi: 10.1097/j.pain.0000000000001361.

PMID:
30086116
15.

The classification of Charcot-Marie-Tooth diseases, a never-ending story: CMT4?

Vallat JM, Tazir M, Magy L, Le Masson G, Mathis S.

Brain. 2018 Sep 1;141(9):e70. doi: 10.1093/brain/awy207. No abstract available.

PMID:
30084872
16.

Pathology of Nerve Biopsy and Diagnostic Yield of PCR-Based Clonality Testing in Neurolymphomatosis.

Duchesne M, Roussellet O, Maisonobe T, Gachard N, Rizzo D, Armand M, Viala K, Richard L, Delage-Corre M, Jaccard A, Corcia P, Vallat JM, Magy L.

J Neuropathol Exp Neurol. 2018 Sep 1;77(9):769-781. doi: 10.1093/jnen/nly055.

PMID:
30011033
17.

Fingolimod and CIDP: insights from negative results.

Magy L.

Lancet Neurol. 2018 Aug;17(8):655-656. doi: 10.1016/S1474-4422(18)30246-1. Epub 2018 Jul 9. No abstract available.

PMID:
30001924
18.

Value of nerve biopsy in the management of peripheral neuropathies.

Mathis S, Magy L, Le Masson G, Richard L, Soulages A, Solé G, Duval F, Ghorab K, Vallat JM, Duchesne M.

Expert Rev Neurother. 2018 Jul;18(7):589-602. doi: 10.1080/14737175.2018.1489240. Epub 2018 Jun 25. Review.

PMID:
29923431
19.

Subacute nodopathy with conduction blocks and anti-neurofascin 140/186 antibodies: an ultrastructural study.

Vallat JM, Mathis S, Magy L, Bounolleau P, Skarzynski M, Heitzmann A, Manso C, Devaux J, Uncini A.

Brain. 2018 Jul 1;141(7):e56. doi: 10.1093/brain/awy134. No abstract available.

PMID:
29800077
20.

Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study.

Hachulla E, Le Masson G, Solé G, Hamidou M, Desnuelle C, Azulay JP, Besson G, Swiader L, Abad S, Antoine JC, Bouhour F, Créange A, Grenouillet M, Magy L, Marcel S, Paquet JM, Rouhart F, Ziegler F, Mathis S, Gauthier-Darnis M, Puget S.

Biomed Res Int. 2018 Mar 15;2018:8147251. doi: 10.1155/2018/8147251. eCollection 2018.

21.

Assessing sudomotor impairment in patients with peripheral neuropathy: Comparison between electrochemical skin conductance and skin biopsy.

Duchesne M, Richard L, Vallat JM, Magy L.

Clin Neurophysiol. 2018 Jul;129(7):1341-1348. doi: 10.1016/j.clinph.2018.04.608. Epub 2018 Apr 27.

PMID:
29729587
22.

Heterogeneous pattern of autonomic dysfunction in Parkinson's disease.

Leclair-Visonneau L, Magy L, Volteau C, Clairembault T, Le Dily S, Préterre C, Peyre A, Damier P, Neunlist M, Péréon Y, Derkinderen P.

J Neurol. 2018 Apr;265(4):933-941. doi: 10.1007/s00415-018-8789-8. Epub 2018 Feb 20.

PMID:
29464374
23.

Updating the classification of inherited neuropathies: Results of an international survey.

Magy L, Mathis S, Le Masson G, Goizet C, Tazir M, Vallat JM.

Neurology. 2018 Mar 6;90(10):e870-e876. doi: 10.1212/WNL.0000000000005074. Epub 2018 Feb 2.

PMID:
29429969
24.

Skin Biopsy Findings in Patients With CMT1A: Baseline Data From the CLN-PXT3003-01 Study Provide New Insights Into the Pathophysiology of the Disorder.

Duchesne M, Danigo A, Richard L, Vallat JM, Attarian S, Gonnaud PM, Lacour A, Péréon Y, Stojkovic T, Nave KA, Bertrand V, Nabirotchkin S, Cohen D, Demiot C, Magy L.

J Neuropathol Exp Neurol. 2018 Apr 1;77(4):274-281. doi: 10.1093/jnen/nly001.

PMID:
29408953
25.

Nerve Biopsy Is Still Useful in Some Inherited Neuropathies.

Duchesne M, Mathis S, Richard L, Magdelaine C, Corcia P, Nouioua S, Tazir M, Magy L, Vallat JM.

J Neuropathol Exp Neurol. 2018 Feb 1;77(2):88-99. doi: 10.1093/jnen/nlx111. Review.

PMID:
29300988
26.

History and current difficulties in classifying inherited myopathies and muscular dystrophies.

Mathis S, Tazir M, Magy L, Duval F, Le Masson G, Duchesne M, Couratier P, Ghorab K, Solé G, Lacoste I, Goizet C, Vallat JM.

J Neurol Sci. 2018 Jan 15;384:50-54. doi: 10.1016/j.jns.2017.10.051. Epub 2017 Nov 2.

PMID:
29249377
27.

Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features.

Svahn J, Petiot P, Antoine JC, Vial C, Delmont E, Viala K, Steck AJ, Magot A, Cauquil C, Zarea A, Echaniz-Laguna A, Iancu Ferfoglia R, Gueguen A, Magy L, Léger JM, Kuntzer T, Ferraud K, Lacour A, Camdessanché JP; Francophone anti-MAG cohort Group.

J Neurol Neurosurg Psychiatry. 2018 May;89(5):499-505. doi: 10.1136/jnnp-2017-316715. Epub 2017 Oct 25.

PMID:
29070644
28.

Did Jules Dejerine describe AMAN at the end of the 19th century?

Mathis S, Magy L, Le Masson G, Vallat JM.

Neurology. 2017 Oct 17;89(16):1749-1753. doi: 10.1212/WNL.0000000000004527.

PMID:
29038133
29.

Candesartan prevents resiniferatoxin-induced sensory small-fiber neuropathy in mice by promoting angiotensin II-mediated AT2 receptor stimulation.

Bessaguet F, Danigo A, Magy L, Sturtz F, Desmoulière A, Demiot C.

Neuropharmacology. 2017 Nov;126:142-150. doi: 10.1016/j.neuropharm.2017.08.039. Epub 2017 Sep 5.

PMID:
28882562
30.

OnabotulinumtoxinA injections in chronic migraine, targeted to sites of pericranial myofascial pain: an observational, open label, real-life cohort study.

Ranoux D, Martiné G, Espagne-Dubreuilh G, Amilhaud-Bordier M, Caire F, Magy L.

J Headache Pain. 2017 Dec;18(1):75. doi: 10.1186/s10194-017-0781-7. Epub 2017 Jul 21.

31.

[An asynchronous bilateral optic neuropathy with positive MOG antibodies].

Lathiere T, Robert PY, Magy L, Dost L, Montcuquet A.

J Fr Ophtalmol. 2017 Jun;40(6):e211-e213. doi: 10.1016/j.jfo.2016.04.010. Epub 2017 Jun 3. French. No abstract available.

PMID:
28583697
32.

Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy.

Maddur MS, Stephen-Victor E, Das M, Prakhar P, Sharma VK, Singh V, Rabin M, Trinath J, Balaji KN, Bolgert F, Vallat JM, Magy L, Kaveri SV, Bayry J.

J Neuroinflammation. 2017 Mar 20;14(1):58. doi: 10.1186/s12974-017-0818-5.

33.

[Peripheral neuropathies: Diagnostic strategy].

Magy L.

Rev Med Interne. 2018 Jan;39(1):27-33. doi: 10.1016/j.revmed.2017.01.015. Epub 2017 Mar 1. Review. French.

PMID:
28258866
34.

Phenotypic spectrum of Charcot-Marie-Tooth disease due to LITAF/SIMPLE mutations: a study of 18 patients.

Guimarães-Costa R, Iancu Ferfoglia R, Leonard-Louis S, Ziegler F, Magy L, Fournier E, Dubourg O, Bouche P, Maisonobe T, Lacour A, Moerman A, Latour P, Stojkovic T.

Eur J Neurol. 2017 Mar;24(3):530-538. doi: 10.1111/ene.13239.

PMID:
28211240
35.

A Rasch Analysis of the Charcot-Marie-Tooth Neuropathy Score (CMTNS) in a Cohort of Charcot-Marie-Tooth Type 1A Patients.

Wang W, Guedj M, Bertrand V, Foucquier J, Jouve E, Commenges D, Proust-Lima C, Murphy NP, Blin O, Magy L, Cohen D, Attarian S.

PLoS One. 2017 Jan 17;12(1):e0169878. doi: 10.1371/journal.pone.0169878. eCollection 2017.

36.

Simultaneous Combined Myositis, Inflammatory Polyneuropathy, and Overlap Myasthenic Syndrome.

Mathis S, Magy L, Corcia P, Ghorab K, Richard L, Ciron J, Duchesne M, Vallat JM.

Case Rep Neurol Med. 2016;2016:6108234. doi: 10.1155/2016/6108234. Epub 2016 Dec 1.

37.

Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies.

Vallat JM, Yuki N, Sekiguchi K, Kokubun N, Oka N, Mathis S, Magy L, Sherman DL, Brophy PJ, Devaux JJ.

Neuromuscul Disord. 2017 Mar;27(3):290-293. doi: 10.1016/j.nmd.2016.10.008. Epub 2016 Oct 24.

38.

Contactin-Associated Protein 1 (CNTNAP1) Mutations Induce Characteristic Lesions of the Paranodal Region.

Vallat JM, Nizon M, Magee A, Isidor B, Magy L, Péréon Y, Richard L, Ouvrier R, Cogné B, Devaux J, Zuchner S, Mathis S.

J Neuropathol Exp Neurol. 2016 Dec 1;75(12):1155-1159. doi: 10.1093/jnen/nlw093.

39.

Thalidomide and POEMS syndrome: a cautious step forward.

Jaccard A, Magy L.

Lancet Neurol. 2016 Oct;15(11):1104-5. doi: 10.1016/S1474-4422(16)30176-4. Epub 2016 Aug 3. No abstract available.

PMID:
27496679
40.

Contribution of dot-blot assay to the diagnosis and management of myositis: a three-year practice at a university hospital centre.

Martel C, Vignaud G, Liozon E, Magy L, Gallouedec G, Ly K, Bezanahary H, Cypierre A, Lapébie FX, Palat S, Gondran G, Jauberteau MO, Fauchais AL.

Clin Exp Rheumatol. 2016 Sep-Oct;34(5):918-924. Epub 2016 Aug 2.

PMID:
27494325
41.

Reasons Charcot-Marie-Tooth disease due to mutations in the MME gene should not be named AR-CMT2T.

Mathis S, Goizet C, Tazir M, Magy L, Vallat JM.

Ann Neurol. 2016 Sep;80(3):477. doi: 10.1002/ana.24741. Epub 2016 Aug 4. No abstract available.

PMID:
27458975
42.

Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A.

Attarian S, Vallat JM, Magy L, Funalot B, Gonnaud PM, Lacour A, Péréon Y, Dubourg O, Pouget J, Micallef J, Franques J, Lefebvre MN, Ghorab K, Al-Moussawi M, Tiffreau V, Preudhomme M, Magot A, Leclair-Visonneau L, Stojkovic T, Bossi L, Lehert P, Gilbert W, Bertrand V, Mandel J, Milet A, Hajj R, Boudiaf L, Scart-Grès C, Nabirotchkin S, Guedj M, Chumakov I, Cohen D.

Orphanet J Rare Dis. 2016 Jul 7;11(1):92. No abstract available.

43.

Therapeutic options and management of polyneuropathy associated with anti-MAG antibodies.

Vallat JM, Magy L, Ciron J, Corcia P, Le Masson G, Mathis S.

Expert Rev Neurother. 2016 Sep;16(9):1111-9. doi: 10.1080/14737175.2016.1198257. Epub 2016 Jun 16. Review.

PMID:
27267749
44.

Classifications of neurogenetic diseases: An increasingly complex problem.

Vallat JM, Goizet C, Tazir M, Couratier P, Magy L, Mathis S.

Rev Neurol (Paris). 2016 Jun-Jul;172(6-7):339-49. doi: 10.1016/j.neurol.2016.04.005. Epub 2016 May 27. Review.

PMID:
27240993
45.

Congenital hypomyelinating neuropathy due to the association of a truncating mutation in PMP22 with the classical HNPP deletion.

Jouaud M, Gonnaud PM, Richard L, Latour P, Ollagnon-Roman E, Sturtz F, Mathis S, Magy L, Vallat JM.

Neuromuscul Disord. 2016 Apr-May;26(4-5):316-21. doi: 10.1016/j.nmd.2016.01.004. Epub 2016 Apr 5.

PMID:
27067623
46.

The therapeutic potential of renin angiotensin aldosterone system (RAAS) in chronic pain: from preclinical studies to clinical trials.

Bessaguet F, Magy L, Desmoulière A, Demiot C.

Expert Rev Neurother. 2016;16(3):331-9. doi: 10.1586/14737175.2016.1150179. Review.

PMID:
26852820
47.

Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study.

Dogan C, De Antonio M, Hamroun D, Varet H, Fabbro M, Rougier F, Amarof K, Arne Bes MC, Bedat-Millet AL, Behin A, Bellance R, Bouhour F, Boutte C, Boyer F, Campana-Salort E, Chapon F, Cintas P, Desnuelle C, Deschamps R, Drouin-Garraud V, Ferrer X, Gervais-Bernard H, Ghorab K, Laforet P, Magot A, Magy L, Menard D, Minot MC, Nadaj-Pakleza A, Pellieux S, Pereon Y, Preudhomme M, Pouget J, Sacconi S, Sole G, Stojkovich T, Tiffreau V, Urtizberea A, Vial C, Zagnoli F, Caranhac G, Bourlier C, Riviere G, Geille A, Gherardi RK, Eymard B, Puymirat J, Katsahian S, Bassez G.

PLoS One. 2016 Feb 5;11(2):e0148264. doi: 10.1371/journal.pone.0148264. eCollection 2016.

48.

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.

Barbin L, Rousseau C, Jousset N, Casey R, Debouverie M, Vukusic S, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Créange A, Labauge P, Magy L, Defer G, Foucher Y, Laplaud DA; CFSEP and OFSEP groups.

Neurology. 2016 Feb 23;86(8):771-8. doi: 10.1212/WNL.0000000000002395. Epub 2016 Jan 29.

49.

Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.

Mathis S, Vallat JM, Magy L.

Immunotherapy. 2016 Feb;8(2):165-78. doi: 10.2217/imt.15.107. Epub 2016 Jan 25. Review.

PMID:
26809024
50.

Simultaneous Quantification of Unmyelinated Nerve Fibers in Sural Nerve and in Skin.

Duchesne M, Magy L, Richard L, Ingrand P, Neau JP, Mathis S, Vallat JM.

J Neuropathol Exp Neurol. 2016 Jan;75(1):53-60. doi: 10.1093/jnen/nlv005. Epub 2015 Dec 7.

PMID:
26705410

Supplemental Content

Support Center